Note 12 - Grants and Collaboration Revenue

9 Months Ended

Sep. 30, 2019

Government Grants and Contracts [Text Block]

12.	Grants and Collaboration Revenue

We receive payments from government entities under our grants from the National Institute of Allergy and Infectious Diseases (NIAID) and from the U.S. Department of Defense in support of our vaccine research and development efforts. We record revenue associated with government grants as the reimbursable costs are incurred. During the

three

-month and

nine

-month periods ended

September 30, 2019,

we recorded

$214,765

and

$754,022,

respectively, of revenues associated with these grants, as compared to

$340,716

and

$650,280,

respectively, for the comparable periods of

2018.

As of

September 30, 2019,

there is an aggregate of

$1,835,225

in approved grant funds available for use during

2019

and

2020.

During the

three

-month and

nine

-month periods ended

September 30, 2019,

we recorded

$118,444

and

$153,360,

respectively, of revenues associated with research collaboration agreements with

third

parties, as compared to

$8,628

and

$13,628,

respectively, for the comparable periods of

2018.